Cemiplimab
Product Specifications
CAS Number
1801342-60-8
Target
PD-1/PD-L1, Others
Related Pathways
Immunology/Inflammation, Others, Apoptosis, Cell Cycle/Checkpoint
Purity
>97.2%
Bioactivity
Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor. It is applicable in research on metastatic cancer and squamous cell skin cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Human Monoclonal IL-13 Antibody (IMA-026) [Janelia Fluor 635]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-28676JF635 0.1 mL
Human Monoclonal IL-13 Antibody (IMA-026) [Janelia Fluor 635]
Sign In for Pricing
View Details 130109-HRP 100 µL
N4BP2 (NEDD4-binding Protein 2, N4BP2, BCL-3-binding Protein, B3BP, KIAA1413, FLJ10680) (HRP)
Sign In for Pricing
View Details 
D1650-04B-FITC 200 µL
DDR2 (Discoidin Domain-containing Receptor 2, Discoidin Domain Receptor 2, Receptor Protein-tyrosine Kinase TKT, Tyrosine-protein Kinase TYRO10, Neurotrophic Tyrosine Kinase, Receptor-related 3, CD167 Antigen-like Family Member B, CD167b, NTRKR3, TKT, TYRO10) (FITC) discontinued
Sign In for Pricing
View Details